These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29681874)

  • 1. Alexithymia in Gastroenterology and Hepatology: A Systematic Review.
    Carrozzino D; Porcelli P
    Front Psychol; 2018; 9():470. PubMed ID: 29681874
    [No Abstract]   [Full Text] [Related]  

  • 2. Alexithymia and Inflammatory Bowel Disease: A Systematic Review.
    Martino G; Caputo A; Schwarz P; Bellone F; Fries W; Quattropani MC; Vicario CM
    Front Psychol; 2020; 11():1763. PubMed ID: 32973596
    [No Abstract]   [Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome.
    Fournier A; Mondillon L; Luminet O; Canini F; Mathieu N; Gauchez AS; Dantzer C; Bonaz B; Pellissier S
    Front Psychiatry; 2020; 11():229. PubMed ID: 32300314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Emotional and personality features of patients with irritable bowel syndrome and bowel inflammatory diseases].
    Mnatsakanyan MG; Dyukova GM; Pogromov AP; Tashchyan OV
    Klin Med (Mosk); 2016; 94(10):764-9. PubMed ID: 30299020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alexithymia and Psychopathology in Patients Suffering From Inflammatory Bowel Disease: Arising Differences and Correlations to Tailoring Therapeutic Strategies.
    Viganò CA; Beltrami MM; Bosi MF; Zanello R; Valtorta M; Maconi G
    Front Psychiatry; 2018; 9():324. PubMed ID: 30127753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alexithymia and functional gastrointestinal disorders. A comparison with inflammatory bowel disease.
    Porcelli P; Taylor GJ; Bagby RM; De Carne M
    Psychother Psychosom; 1999; 68(5):263-9. PubMed ID: 10516531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of alexithymia on health-related quality of life in inflammatory bowel disease: are there any related factors?
    Iglesias-Rey M; Barreiro-de Acosta M; Caamaño-Isorna F; Vázquez Rodríguez I; Lorenzo González A; Bello-Paderne X; Domínguez-Muñoz JE
    Scand J Gastroenterol; 2012 Apr; 47(4):445-53. PubMed ID: 22300356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alexithymia and psychopathology in patients with psychiatric and functional gastrointestinal disorders.
    Porcelli P; Affatati V; Bellomo A; De Carne M; Todarello O; Taylor GJ
    Psychother Psychosom; 2004; 73(2):84-91. PubMed ID: 14767150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status.
    Bryant RV; van Langenberg DR; Holtmann GJ; Andrews JM
    J Gastroenterol Hepatol; 2011 May; 26(5):916-23. PubMed ID: 21214889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
    Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.
    Farrokhyar F; Marshall JK; Easterbrook B; Irvine EJ
    Inflamm Bowel Dis; 2006 Jan; 12(1):38-46. PubMed ID: 16374257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review.
    Martino G; Caputo A; Vicario CM; Catalano A; Schwarz P; Quattropani MC
    Front Psychol; 2020; 11():2026. PubMed ID: 32982843
    [No Abstract]   [Full Text] [Related]  

  • 15. The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
    Trieschmann K; Chang L; Park S; Naliboff B; Joshi S; Labus JS; Sauk JS; Limketkai BN; Mayer EA
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14384. PubMed ID: 35478469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease.
    Verissimo R; Mota-Cardoso R; Taylor G
    Psychother Psychosom; 1998; 67(2):75-80. PubMed ID: 9556198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of alexithymia on persistent symptoms of dyspepsia after laparoscopic cholecystectomy.
    Porcelli P; Lorusso D; Taylor GJ; Bagby RM
    Int J Psychiatry Med; 2007; 37(2):173-84. PubMed ID: 17953235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
    Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.